Search research articles
Contact Us
Filters
Showing results (91-100 of 418) with videos related to
Page
of 42
Sort By:
International Journal of Dermatology
|
June 9, 2005
Development of the US PSORIQoL: a psoriasis-specific measure of quality of life
Stephen P McKenna, Mark Lebwohl, Kristijan N Kahler
Journal of the American Academy of Dermatology
|
March 23, 2020
Should biologics for psoriasis be interrupted in the era of COVID-19?
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology
|
April 14, 2020
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Dermatologic Therapy
|
April 27, 2010
Psoriasis and the metabolic syndrome
Mohammed Ahmed Alsufyani, Alexandra K Golant, Mark Lebwohl
Cancer Letters
|
July 27, 2002
Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein
Huachen Wei, Xueshu Zhang, Yan Wang, et al.
JAMA Dermatology
|
January 22, 2015
Indications and limitations of afamelanotide for treating vitiligo-reply
Henry W Lim, Pearl E Grimes, Mark Lebwohl
The American Journal of Managed Care
|
March 4, 2026
Exploring novel management options for alopecia areata
Libbi Green, Emma Guttman, Mark Lebwohl, et al.
European Journal of Dermatology : EJD
|
April 16, 2003
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis
Jean-Paul Ortonne, Mark Lebwohl, Christopher Em Griffiths, et al.
JAAD Case Reports
|
December 6, 2021
New onset and exacerbation of psoriasis after COVID-19 vaccination
Nancy Wei, Mindy Kresch, Emily Elbogen, et al.
The Journal of Dermatological Treatment
|
October 28, 2003
Case studies in severe psoriasis: A clinical strategy
Mark Lebwohl, Alan Menter, John Koo, et al.
Page
of 42
Search research articles
Search
Showing results (91-100 of 418) with videos related to
Sort By:
Page
of 42
International Journal of Dermatology
|
June 9, 2005
Development of the US PSORIQoL: a psoriasis-specific measure of quality of life
Stephen P McKenna, Mark Lebwohl, Kristijan N Kahler
Journal of the American Academy of Dermatology
|
March 23, 2020
Should biologics for psoriasis be interrupted in the era of COVID-19?
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Journal of the American Academy of Dermatology
|
April 14, 2020
Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution"
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell
Dermatologic Therapy
|
April 27, 2010
Psoriasis and the metabolic syndrome
Mohammed Ahmed Alsufyani, Alexandra K Golant, Mark Lebwohl
Cancer Letters
|
July 27, 2002
Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein
Huachen Wei, Xueshu Zhang, Yan Wang, et al.
JAMA Dermatology
|
January 22, 2015
Indications and limitations of afamelanotide for treating vitiligo-reply
Henry W Lim, Pearl E Grimes, Mark Lebwohl
The American Journal of Managed Care
|
March 4, 2026
Exploring novel management options for alopecia areata
Libbi Green, Emma Guttman, Mark Lebwohl, et al.
European Journal of Dermatology : EJD
|
April 16, 2003
Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis
Jean-Paul Ortonne, Mark Lebwohl, Christopher Em Griffiths, et al.
JAAD Case Reports
|
December 6, 2021
New onset and exacerbation of psoriasis after COVID-19 vaccination
Nancy Wei, Mindy Kresch, Emily Elbogen, et al.
The Journal of Dermatological Treatment
|
October 28, 2003
Case studies in severe psoriasis: A clinical strategy
Mark Lebwohl, Alan Menter, John Koo, et al.
Page
of 42